The short answer
Losing embryos between day 3 and day 5 is expected: in one large series, about half of day-3 embryos never became a usable blastocyst 5. Labs are judged on the share of fertilised eggs reaching blastocyst by day 5, with 40% as the minimum across their reference patients 1. A single cycle below that is not proof of a problem.
On day 3 the lab told you there were several embryos. By day 5 there were fewer, perhaps one, perhaps none to transfer or freeze. It can feel as though something went wrong in those two days.
This page explains how much attrition between day 3 and day 5 is normal, how age changes the picture, how to compare your cycle with a lab's benchmarks without over-reading one result, and what the evidence says about transferring on day 3 instead of day 5 when only a few embryos develop 1,2.
How common is this?
about half
Day-3 embryos that did not become a blastocyst good enough to biopsy by day 5–7 (16,285 of 33,999 embryos, one Abu Dhabi centre, PGT-A cycles)5
40%
Benchmark 60%
Minimum lab average for normally fertilised eggs that become blastocysts on day 5, in the lab's reference group of women under 40 using their own fresh eggs1
27%
Fresh day-5 cycles in women aged 38–45 where transfer was cancelled because no blastocyst formed (one Israeli centre, 2011–2021)6
2–6% → 53%
Patients with no chromosomally normal blastocyst among those biopsied: ages 26–37 vs age 444
Reading your report
- 2PN zygote
- A normally fertilised egg on day 1. Labs count blastocyst development against this number, not against eggs collected 1.
- Day 2 / day 3 (cleavage stage)
- The embryo is dividing into cells. The Vienna consensus uses 4 cells on day 2 and 8 cells on day 3 as the reference points 1.
- Fragmentation
- Small pieces of cell material inside a day-2 or day-3 embryo, often graded by percentage. More fragmentation lowers the chance of reaching blastocyst 5.
- Morula / compaction
- Day 4: the cells pack tightly together before a fluid cavity forms.
- Blastocyst
- A day 5–7 embryo with a fluid cavity, an inner cell mass that becomes the baby and an outer layer that becomes the placenta.
- Arrested embryo
- An embryo that stopped dividing and will not develop further in the lab.
- Blastocyst development rate
- Blastocysts on day 5 divided by normally fertilised eggs on day 1. A lab measure, reported across many patients 1.
Likely causes, most common first
| Cause | How you'd know | Test that tells you |
|---|---|---|
| Chromosomal errors in the embryo | You usually can't: chromosome testing is only done on embryos that reach blastocyst. In 15,169 biopsies, aneuploidy rose steadily after age 26, and the share of patients with no normal blastocyst reached 33% at 42 4. | None for embryos that arrested; PGT-A applies only to blastocysts that form 7 |
| Egg factors, including age | Older age is linked with fewer embryos and fewer blastocysts per cycle; in 764 Chinese cycles, each extra year of female age independently lowered the odds of getting a transferable day-5 blastocyst 10. | No test measures egg quality directly; age and the number of eggs are the practical markers |
| Sperm factors | ESHRE notes that abnormal sperm concentration, motility and morphology are associated with poor embryo development 3. | Semen analysis and a male fertility evaluation (see the male-factor page) |
| Slow or fragmented embryos on day 3 | In the Abu Dhabi series, day-3 embryos with fewer than 6 cells were far less likely to reach blastocyst than those with 6–10 cells, and higher fragmentation lowered the odds step by step 5. | The day-3 section of your embryology report |
| Culture conditions in the lab | Not from one cycle. The Vienna consensus lists observation timing, culture medium and culture conditions, especially oxygen level, as factors that affect blastocyst rates 1. | Ask the lab for its blastocyst development rate over the past year 1 |
What did not cause this
"Stress stopped the embryos growing"
Embryos grow in an incubator, not in your body. A BMJ meta-analysis of 14 prospective studies (3,583 women) also found that pre-treatment anxiety or depression was not associated with whether a cycle led to pregnancy 13.
"If they had been put back on day 3, they would have survived"
There is no way to know whether an embryo that stopped in the lab would have developed in the uterus. In women aged 38–45 at one centre, pregnancy and live birth rates did not differ between day-3 and day-5 transfers 6.
"The lab must have done something wrong"
The Vienna consensus benchmarks are averages across a lab's reference patients 1. Even at the Vienna benchmark, around 4 in 10 fertilised eggs do not reach blastocyst by day 5 1, and in a series of 33,999 day-3 embryos about half did not reach a usable blastocyst 5.
How many embryos normally stop between day 3 and day 5?
More than most people expect. In a series of 33,999 day-3 embryos from 5,702 cycles at one Abu Dhabi centre, 16,285, about half, did not become an expanded blastocyst good enough to biopsy by day 5, 6 or 7 5. That was a clinic doing chromosome testing, so the figure describes one setting, not a universal rate.
The Vienna consensus asks labs to get at least 40% of normally fertilised eggs to blastocyst by day 5 across their reference patients, with 60% as the benchmark 1. It also notes that a further 10–15% of embryos may become blastocysts on day 6 1, so an embryo that is not yet a blastocyst on day 5 is not necessarily finished.
Seen the other way, even a lab at the benchmark loses around 4 in 10 fertilised eggs before day 5 on average 1. With only two or three embryos, losing all of them can happen by chance.
Does age make more embryos stop growing?
Age clearly reduces how many embryos and blastocysts a cycle produces. In a Thai study of women aged 35–46, the median number of day-3 embryos fell from 8 in the youngest group to 4 in the oldest, and blastocysts from 6 to 3 11. In 764 Chinese cycles, female age independently predicted a lower chance of having a transferable day-5 blastocyst 10.
Whether each individual embryo is less likely to reach day 5 with age is less clear. In the same Thai study, the blastulation rate, around 71%, did not differ between age groups 11. The age effect that is well documented is chromosomal: aneuploidy rises steadily after 26, and among patients with blastocysts biopsied, the share with no chromosomally normal blastocyst was 2–6% at 26–37, 33% at 42 and 53% at 44 4.
So at 40 and above, fewer embryos reaching day 5, and fewer of those being chromosomally normal, is the expected pattern rather than a sign that something unusual went wrong. The studies above come from Thailand, China and the USA; we did not find comparable Indian data.
Was it the lab, the eggs or the sperm?
Start with the lab's own numbers. The Vienna consensus gives competency and benchmark values of 50% and 80% for 4-cell embryos on day 2, 45% and 70% for 8-cell embryos on day 3, and 40% and 60% for blastocysts on day 5, all as a share of normally fertilised eggs 1. These apply to a reference group of women under 40 with their own fresh eggs and ejaculated sperm 1. If the lab's yearly figures are within range, one poor cycle points more towards the embryos than the incubator.
Then look at the pattern within your cycle. If fertilisation was normal but embryos were slow or fragmented by day 3, the Abu Dhabi data show that those embryos were much less likely to reach blastocyst 5. If fertilisation itself was low, the fertilisation page is the better starting point.
Sperm deserves a look too. ESHRE's implantation-failure group notes that abnormal sperm concentration, motility and morphology are associated with poor embryo development 3, so a recent semen analysis belongs in the review, not only tests on the woman.
Day 3 or day 5 transfer when only a few embryos develop?
The 2026 Cochrane review of 36 randomised trials (8,389 women) found that a fresh blastocyst transfer probably gives a higher live birth rate per transfer than a day 2–3 transfer: where 32% of women have a live birth after a cleavage-stage transfer, 37–43% would after a blastocyst transfer (moderate certainty) 2. Over all fresh and frozen transfers from one egg collection, blastocyst transfer may give a higher cumulative live birth rate, but that evidence is low certainty and one large trial with two or more transfers per woman found little difference 2.
The trade-offs point the other way. With blastocyst culture, the chance of having no embryo to transfer was higher (odds ratio 2.69), fewer women had spare embryos to freeze, and preterm birth was probably more common 2. Most importantly for this page, the Cochrane authors say their findings should not be applied to women with a poor prognosis, who were under-represented in the trials 2.
For women with few embryos, the evidence is thinner. In a retrospective study of 346 women aged 38–45 at one Israeli centre, 27% of day-5 cycles ended with no transfer because no blastocyst formed, yet pregnancy and live birth rates were no different between day-3 and day-5 transfers 6. A randomised trial in 388 women under 39 with at least four fertilised eggs also found no significant difference in delivery rates 12.
The Israeli authors concluded that in older women, culturing to day 5 avoids transfers unlikely to succeed without lowering pregnancy rates 6; transferring on day 3 avoids the disappointment of a cancelled transfer. The evidence does not show either as clearly better when embryos are few. ESHRE's implantation-failure group says blastocyst transfer can be considered after repeated implantation failure 3.
Can anything help more embryos reach day 5 next time?
No add-on has good evidence that it does. Many things sold for 'egg quality' or 'embryo development' have been reviewed by ESHRE and the HFEA, and the ratings are below.
PGT-A does not create more blastocysts; it tests the ones that form. ESHRE does not recommend it for routine use 7, and the HFEA rates it red for the chance of a baby for most patients 8. Time-lapse imaging is rated black by the HFEA, meaning it has no effect on the chance of a baby 8.
Calcium ionophores are sometimes used after previous embryo arrest. A subgroup of 4 studies (461 patients) with embryo developmental problems suggested benefit, but ESHRE explicitly left this use out of its recommendation, which covers only fertilisation failure and globozoospermia 7.
A change of stimulation protocol is a separate question, covered on the protocol page. More eggs usually mean more embryos to start with, but we did not find evidence that any particular protocol reduces the share of embryos that arrest.
What's worth checking
- Get the day-by-day embryology report: 2PN on day 1, cell number and fragmentation on days 2 and 3, and blastocyst stage and grade on days 5 and 6.
- Check whether embryos were watched to day 6 before being called arrested 1.
- Ask the lab for its blastocyst development rate over the past year for patients under 40 and for your age group 1.
- Note how many eggs were collected and how many fertilised, since fewer starting embryos means more chance of losing them all.
- Ask for a recent semen analysis for your partner, and a male evaluation if it is abnormal 3.
- List each previous cycle's day-3 and day-5 counts, to see whether this is a pattern.
- Before paying for an add-on, ask for its ESHRE recommendation and HFEA rating.
What could change next cycle
9 options, by strength of evidence
- Mixed, or some groups only 2
- Not enough studies yet 4
- Evidence says it doesn't help 3
Ratings follow the evidence reviews cited beside each option, not our opinion.
- Culturing to day 5 againMixed, or some groups only
Cochrane 2026: higher live birth per fresh transfer in good-prognosis women, but more cancelled transfers; not tested in poor-prognosis women 2.
- Day-3 transfer when few embryos are expectedMixed, or some groups only
No worse live birth in one retrospective study of women 38–45 6; Cochrane findings do not apply to poor prognosis 2.
- PGT-AEvidence says it doesn't help
HFEA: red for chance of a baby, green for reducing miscarriage 8; ESHRE: not routine 7. It tests blastocysts, it does not make more.
- Time-lapse imaging and incubationEvidence says it doesn't help
HFEA: black 8; ESHRE: not recommended to improve live birth 7.
- Calcium ionophore after previous embryo arrestNot enough studies yet
4 studies, 461 patients; ESHRE did not include this use in its recommendation 7.
- DHEA before or during stimulationEvidence says it doesn't help
ESHRE 2025: not recommended for low or normal responders (strong recommendation) 9.
- Growth hormone before or during stimulationNot enough studies yet
ESHRE 2025: not recommended for normal responders, probably not for low responders; very low-quality evidence 9.
- Antioxidant supplementsNot enough studies yet
ESHRE: effect on live birth uncertain, not recommended in ART 7.
- Mitochondrial replacement to improve egg qualityNot enough studies yet
ESHRE: few data, no live-birth benefit shown, not recommended 7.
Questions to ask your doctor
- How did my embryos compare with this lab's usual day-3 and day-5 development for someone my age?
- Were the embryos observed on day 6 before being discarded as arrested?
- Does the pattern in my report point more towards egg, sperm or culture factors?
- With the number of eggs you expect from me, would you culture to day 5 or transfer on day 3, and why?
- Should my partner have a semen analysis or male evaluation before the next cycle?
- Would you change anything in stimulation, and what evidence is that based on?
Questions people ask
Can an embryo that stopped on day 4 start growing again?
The Vienna consensus notes that some embryos reach blastocyst only on day 6, adding about 10–15% more blastocysts 1. An embryo that has clearly stopped dividing is not expected to restart, which is why labs record it as arrested.
Are day-6 blastocysts worse than day-5 blastocysts?
The Vienna consensus counts day-6 blastocysts as a separate, additional group rather than failures 1. Whether a day-6 blastocyst has a lower chance than a day-5 one was outside the sources reviewed for this page; ask your clinic for its own results.
Does ICSI make embryos more likely to stop growing?
In the 33,999-embryo Abu Dhabi series, the insemination method (IVF or ICSI) was not associated with reaching blastocyst once other factors were accounted for 5.
What if no embryo reached day 5 in two cycles?
How many blastocysts should I get from 10 eggs?
The Vienna consensus sets a figure for each step: at least 65% of injected mature eggs should fertilise normally after ICSI (benchmark 80%), and at least 40% of normally fertilised eggs should be blastocysts on day 5 (benchmark 60%) 1. Applied to 10 mature eggs that works out at roughly 3 blastocysts at the lower figures and about 5 at the benchmark 1. These are laboratory averages, not a forecast for one cycle.
Do immature eggs count in the blastocyst rate my clinic quotes?
No. The Vienna consensus calculates blastocyst development rate from normally fertilised eggs on day 1, not from every egg collected, and the ICSI fertilisation rate from mature (MII) eggs injected 1. How many eggs were mature is tracked separately, as oocyte maturity rate 1. So the number you were told at collection and the number the laboratory is judged on are different figures.
Can a normal 8-cell embryo on day 3 still fail to reach day 5?
Often, yes. In the Abu Dhabi series of 33,999 day-3 embryos, those with 6 to 10 cells went on to make a blastocyst good enough to biopsy in 13,531 of 23,297 cases, about 58%, and embryos with 10% fragmentation or less in about 60% 5. A textbook day-3 embryo is a better bet than a slow or fragmented one, not a certainty.
Can the embryos that stopped growing be tested to find out why?
Not in normal practice. Chromosome testing is done on a biopsy taken from an expanded blastocyst that has an inner cell mass and an outer layer, so an embryo that arrested earlier is never tested 5,7. ESHRE does not recommend PGT-A for routine use, and it sorts the embryos that form rather than explaining the ones that stopped 7.
Does having more fertilised eggs improve the chance of at least one blastocyst?
It does. In 764 Chinese cycles, the independent predictors of getting a transferable day-5 blastocyst were the number of normally fertilised (2PN) embryos, the number of good-quality embryos, the number with more than 10 cells on day 3, and an age measure 10. More embryos at the start does not change the share that arrest; it changes the chance that one gets through.
Does a cycle cancelled before transfer count as a failed IVF cycle?
Not as an implantation failure. ESHRE describes recurrent implantation failure as the transfer of embryos considered viable failing to give a positive test, and sets its 60% threshold on the cumulative chance from embryos actually transferred 3. A cycle that ended before transfer adds nothing to that total, so it points towards egg and embryo questions rather than towards an implantation workup.
Who decides which blastocysts are good enough to freeze?
The laboratory does, against its own criteria. The Vienna group looked at embryo and blastocyst utilisation rates, meaning embryos suitable for transfer or freezing per fertilised egg, and concluded that practice differs so much between laboratories that no reference values could be agreed 1. Ask your clinic, before the next cycle, what its threshold for freezing is.
Does a low AMH mean my embryos won't reach blastocyst?
AMH mostly predicts how many eggs, not how they develop. In the 33,999-embryo model, AMH was one of the patient factors tested, but the final model for whether an embryo became a blastocyst kept only female age, day-3 cell count and fragmentation 5. Fewer eggs still lowers the chance that at least one blastocyst forms, because there are fewer chances 10.
Sources
- ESHRE Special Interest Group of Embryology and Alpha Scientists in Reproductive Medicine. The Vienna consensus: report of an expert meeting on the development of ART laboratory performance indicators. Hum Reprod Open. 2017;2017(2):hox011. ESHRE / ALPHA / Human Reproduction Open
- Glujovsky D, Cornelisse S, Blake D, Quinteiro Retamar AM, Alvarez Sedo CR, Ciapponi A. Blastocyst-stage versus cleavage-stage embryo transfer in assisted reproductive technology. Cochrane Database Syst Rev. 2026;1(1):CD002118. Cochrane
- ESHRE Working Group on Recurrent Implantation Failure; Cimadomo D, de los Santos MJ, Griesinger G, et al. ESHRE good practice recommendations on recurrent implantation failure. Hum Reprod Open. 2023;2023(3):hoad023. ESHRE / Human Reproduction Open
- Franasiak JM, Forman EJ, Hong KH, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656–663.e1. Fertility and Sterility
- Elkhatib I, Kalafat E, Bayram A, et al. Blastulation and ploidy prediction using morphology assessment in 33,999 day-3 embryos. Sci Rep. 2025;15:43475. Scientific Reports
- Giladi Yacobi E, Miller N, Gepstein NG, et al. Does cleavage- versus blastocyst-stage embryo transfer improve fertility rates in women over 38 years of age undergoing assisted reproductive technology? Int J Gynaecol Obstet. 2024;167(3):1017–1022. International Journal of Gynecology & Obstetrics
- ESHRE Add-ons working group; Lundin K, Bentzen JG, Bozdag G, Ebner T, Harper J, et al. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023;38(11):2062–2104. ESHRE / Human Reproduction
- Human Fertilisation and Embryology Authority. Treatment add-ons with limited evidence (ratings list), with the PGT-A and time-lapse imaging rating pages. HFEA (UK regulator)
- ESHRE Guideline Group on Ovarian Stimulation; Ata B, Bosch E, Broer S, et al. ESHRE guideline: ovarian stimulation for IVF/ICSI: an update in 2025. Hum Reprod. 2026;41(4):498–514. ESHRE / Human Reproduction
- Ji H, Bai Q, Ding L, et al. Prediction of blastocyst development using cleavage-stage embryo metrics and maternal age. Sci Rep. 2025;15:24511. Scientific Reports
- Santamonkunrot P, Samutchinda S, Niransuk P, Satirapod C, Sukprasert M. The association between embryo development and chromosomal results from PGT-A in women of advanced age: a prospective cohort study. J Clin Med. 2024;13(2):626. Journal of Clinical Medicine
- Levi-Setti PE, Cirillo F, Smeraldi A, Morenghi E, Mulazzani GEG, Albani E. No advantage of fresh blastocyst versus cleavage stage embryo transfer in women under the age of 39: a randomized controlled study. J Assist Reprod Genet. 2018;35(3):457–465. Journal of Assisted Reproduction and Genetics
- Boivin J, Griffiths E, Venetis CA. Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies. BMJ. 2011;342:d223. BMJ